These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
580 related articles for article (PubMed ID: 20020773)
1. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. Freibaum BD; Chitta RK; High AA; Taylor JP J Proteome Res; 2010 Feb; 9(2):1104-20. PubMed ID: 20020773 [TBL] [Abstract][Full Text] [Related]
2. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. Liu-Yesucevitz L; Bilgutay A; Zhang YJ; Vanderweyde T; Citro A; Mehta T; Zaarur N; McKee A; Bowser R; Sherman M; Petrucelli L; Wolozin B PLoS One; 2010 Oct; 5(10):e13250. PubMed ID: 20948999 [TBL] [Abstract][Full Text] [Related]
3. Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes. Russo A; Scardigli R; La Regina F; Murray ME; Romano N; Dickson DW; Wolozin B; Cattaneo A; Ceci M Hum Mol Genet; 2017 Apr; 26(8):1407-1418. PubMed ID: 28158562 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneous Nuclear Ribonucleoprotein E2 (hnRNP E2) Is a Component of TDP-43 Aggregates Specifically in the A and C Pathological Subtypes of Frontotemporal Lobar Degeneration. Kattuah W; Rogelj B; King A; Shaw CE; Hortobágyi T; Troakes C Front Neurosci; 2019; 13():551. PubMed ID: 31213972 [TBL] [Abstract][Full Text] [Related]
5. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies. Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339 [TBL] [Abstract][Full Text] [Related]
6. Absence of heterogeneous nuclear ribonucleoproteins and survival motor neuron protein in TDP-43 positive inclusions in frontotemporal lobar degeneration. Neumann M; Igaz LM; Kwong LK; Nakashima-Yasuda H; Kolb SJ; Dreyfuss G; Kretzschmar HA; Trojanowski JQ; Lee VM Acta Neuropathol; 2007 May; 113(5):543-8. PubMed ID: 17415574 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD. Shenouda M; Zhang AB; Weichert A; Robertson J Adv Neurobiol; 2018; 20():239-263. PubMed ID: 29916022 [TBL] [Abstract][Full Text] [Related]
8. A90V TDP-43 variant results in the aberrant localization of TDP-43 in vitro. Winton MJ; Van Deerlin VM; Kwong LK; Yuan W; Wood EM; Yu CE; Schellenberg GD; Rademakers R; Caselli R; Karydas A; Trojanowski JQ; Miller BL; Lee VM FEBS Lett; 2008 Jun; 582(15):2252-6. PubMed ID: 18505686 [TBL] [Abstract][Full Text] [Related]
9. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis. Deshaies JE; Shkreta L; Moszczynski AJ; Sidibé H; Semmler S; Fouillen A; Bennett ER; Bekenstein U; Destroismaisons L; Toutant J; Delmotte Q; Volkening K; Stabile S; Aulas A; Khalfallah Y; Soreq H; Nanci A; Strong MJ; Chabot B; Vande Velde C Brain; 2018 May; 141(5):1320-1333. PubMed ID: 29562314 [TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic mislocalization of RNA splicing factors and aberrant neuronal gene splicing in TDP-43 transgenic pig brain. Wang G; Yang H; Yan S; Wang CE; Liu X; Zhao B; Ouyang Z; Yin P; Liu Z; Zhao Y; Liu T; Fan N; Guo L; Li S; Li XJ; Lai L Mol Neurodegener; 2015 Sep; 10():42. PubMed ID: 26334913 [TBL] [Abstract][Full Text] [Related]
11. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies. Igaz LM; Kwong LK; Chen-Plotkin A; Winton MJ; Unger TL; Xu Y; Neumann M; Trojanowski JQ; Lee VM J Biol Chem; 2009 Mar; 284(13):8516-24. PubMed ID: 19164285 [TBL] [Abstract][Full Text] [Related]
12. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Wils H; Kleinberger G; Janssens J; Pereson S; Joris G; Cuijt I; Smits V; Ceuterick-de Groote C; Van Broeckhoven C; Kumar-Singh S Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3858-63. PubMed ID: 20133711 [TBL] [Abstract][Full Text] [Related]
13. TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases. Warraich ST; Yang S; Nicholson GA; Blair IP Int J Biochem Cell Biol; 2010 Oct; 42(10):1606-9. PubMed ID: 20601083 [TBL] [Abstract][Full Text] [Related]
14. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. Winton MJ; Igaz LM; Wong MM; Kwong LK; Trojanowski JQ; Lee VM J Biol Chem; 2008 May; 283(19):13302-9. PubMed ID: 18305110 [TBL] [Abstract][Full Text] [Related]
15. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration. Takeda T Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544 [TBL] [Abstract][Full Text] [Related]
16. Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network. Li Y; Collins M; An J; Geiser R; Tegeler T; Tsantilas K; Garcia K; Pirrotte P; Bowser R Brain Res; 2016 Sep; 1647():79-93. PubMed ID: 26979993 [TBL] [Abstract][Full Text] [Related]
17. TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor. Mohagheghi F; Prudencio M; Stuani C; Cook C; Jansen-West K; Dickson DW; Petrucelli L; Buratti E Hum Mol Genet; 2016 Feb; 25(3):534-45. PubMed ID: 26614389 [TBL] [Abstract][Full Text] [Related]